BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 2 filers reported holding BRIDGEBIO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,853,971 | +68.2% | 1,056,275 | +9.7% | 0.01% | +60.0% |
Q2 2023 | $16,562,757 | +8.0% | 962,951 | +4.1% | 0.01% | 0.0% |
Q1 2023 | $15,333,549 | +152.8% | 924,822 | +16.2% | 0.01% | +150.0% |
Q4 2022 | $6,066,427 | -20.9% | 796,119 | +3.2% | 0.00% | -33.3% |
Q3 2022 | $7,671,000 | -21.1% | 771,656 | -27.9% | 0.00% | 0.0% |
Q2 2022 | $9,718,000 | -11.3% | 1,070,159 | -0.8% | 0.00% | 0.0% |
Q1 2022 | $10,953,000 | -37.2% | 1,079,082 | +3.2% | 0.00% | -40.0% |
Q4 2021 | $17,436,000 | -64.5% | 1,045,290 | -0.2% | 0.01% | -68.8% |
Q3 2021 | $49,096,000 | +10.8% | 1,047,492 | +44.1% | 0.02% | +6.7% |
Q2 2021 | $44,323,000 | +4.3% | 727,082 | +5.4% | 0.02% | -6.2% |
Q1 2021 | $42,476,000 | +13.0% | 689,532 | +30.5% | 0.02% | +6.7% |
Q4 2020 | $37,578,000 | +91.7% | 528,443 | +1.1% | 0.02% | +66.7% |
Q3 2020 | $19,606,000 | +132.7% | 522,543 | +102.2% | 0.01% | +125.0% |
Q2 2020 | $8,427,000 | +14.1% | 258,411 | +1.4% | 0.00% | 0.0% |
Q1 2020 | $7,387,000 | +58.4% | 254,718 | +91.5% | 0.00% | +33.3% |
Q4 2019 | $4,663,000 | +72.0% | 133,031 | +5.4% | 0.00% | +50.0% |
Q3 2019 | $2,711,000 | – | 126,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |